RespireRx Pharmaceuticals Inc (RSPI)

[drfreely]

I don't think CORX will get terms this time around similar to the Samyang deal. It will, however, be framed by management as "buying time" for a resale of RD/SA, results from the MJ Fox mice, et cetera. If they fail to repackage those items into an deal resurrecting ADHD, that will be the time to consider re-entering CORX. Despite its downward spiral, it is my opinion that CORX will need to fall 30 to 40 percent from its current level before it will reach a point of where additional financings simply will not be available on any terms and the management and board will fold up their tents. Until it reaches that level your point is well taken, why allocate funds at this entry point only to watch them be ground away by months of unproductive negotiations.
Of course I could be completely wrong. Management could ink a monster licensing deal in the next thirty to ninety days for RD/SA, with more than enough funds to run a conclusive, speedy, and pressworthy ADHD trail that would leave me at the station long after the bullet train of prosperity has departed the station.